192 related articles for article (PubMed ID: 26928175)
1. Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report.
Ben Zvi M; Vaknine H; Menczer J; Peled O; Ben Shem E; Schreiber L; Levy T
Chemotherapy; 2016; 61(5):236-9. PubMed ID: 26928175
[TBL] [Abstract][Full Text] [Related]
2. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
Wiznia LE; Subtil A; Choi JN
JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
[TBL] [Abstract][Full Text] [Related]
3. [Capecitabine-induced subacute cutaneous lupus: a case report].
Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
Callen JP
JAMA Dermatol; 2013 Sep; 149(9):1075-6. PubMed ID: 23842706
[No Abstract] [Full Text] [Related]
5. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
[TBL] [Abstract][Full Text] [Related]
6. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
[No Abstract] [Full Text] [Related]
7. Long-term disease-free survival effected by gemcitabine in a heavily pretreated patient with recurrent ovarian carcinoma.
Piura B
Arch Gynecol Obstet; 2005 Feb; 271(2):182-3. PubMed ID: 15258813
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine: new indication. Relapsed ovarian cancer: simply more toxic. Increases haematologic toxicity but not overall survival.
Prescrire Int; 2009 Aug; 18(102):156. PubMed ID: 19746525
[No Abstract] [Full Text] [Related]
9. Gemcitabine pulmonary toxicity: CT features.
Boiselle PM; Morrin MM; Huberman MS
J Comput Assist Tomogr; 2000; 24(6):977-80. PubMed ID: 11105721
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine as a single-agent treatment for ovarian cancer.
Fowler WC; Van Le L
Gynecol Oncol; 2003 Aug; 90(2 Pt 2):S21-3. PubMed ID: 12928002
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of gemcitabine in heavily pretreated advanced ovarian cancer patients.
Bilgin T; Ozalp S; Yalçin OT; Zorlu G; Vardar MA; Ozerkan K
Eur J Gynaecol Oncol; 2003; 24(2):169-70. PubMed ID: 12701971
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer.
Watanabe Y; Koike E; Nakai H; Etoh T; Hoshiai H
Int J Clin Oncol; 2008 Aug; 13(4):345-8. PubMed ID: 18704636
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine pulmonary toxicity in ovarian cancer.
Ko E; Lee S; Goodman A
Oncologist; 2008 Jul; 13(7):807-11. PubMed ID: 18614588
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of gemcitabine in ovarian cancer.
von Minckwitz G; Bauknecht T; Visseren-Grul CM; Neijt JP
Ann Oncol; 1999 Jul; 10(7):853-5. PubMed ID: 10470434
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer.
Geisler JP; Schraith DF; Manahan KJ; Sorosky JI
Gynecol Oncol; 2004 Feb; 92(2):705-7. PubMed ID: 14766271
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
Ko JH; Hsieh CI; Chou CY; Wang KH
J Dermatol; 2013 Nov; 40(11):939-40. PubMed ID: 24111883
[No Abstract] [Full Text] [Related]
17. Severe neurotoxicity caused by gemcitabine treatment.
Larsen FO; Hansen SW
Acta Oncol; 2004; 43(6):590-1. PubMed ID: 15370618
[No Abstract] [Full Text] [Related]
18. A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer.
Friedlander M; Millward MJ; Bell D; Bugat R; Harnett P; Moreno JA; Campbell L; Varette C; Ripoche V; Kayitalire L
Ann Oncol; 1998 Dec; 9(12):1343-5. PubMed ID: 9932166
[TBL] [Abstract][Full Text] [Related]
19. [Review of effectiveness of chemotherapy with gemcitabine in ovarian cancer].
Lehoczky O
Orv Hetil; 2005 Nov; 146(46):2351-7. PubMed ID: 16370247
[TBL] [Abstract][Full Text] [Related]
20. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
